F-18 AV 1451 ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
5	Progressive supranuclear palsy	1
127	Frontotemporal lobar degeneration	1

5. Progressive supranuclear palsy

---

Clinical trials : 89 /  Drugs : 107 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02605785 (ClinicalTrials.gov)	November 2015	3/11/2015	A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy	A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy	Progressive Supranuclear Palsy	Drug: F-18 AV 1451	Mayo Clinic	NULL	Recruiting	35 Years	N/A	All	332	N/A	United States

127. Frontotemporal lobar degeneration

---

Clinical trials : 90 /  Drugs : 87 - (DrugBank : 30) / Drug target genes : 39 - Drug target pathways : 88

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02736695 (ClinicalTrials.gov)	July 2016	7/4/2016	Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia	Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and FTD	Primary Progressive Aphasia;Behavioral Variant of Frontotemporal Dementia;Frontotemporal Dementia, Behavioral Variant	Drug: F-18 AV 1451	Mayo Clinic	NULL	Recruiting	18 Years	N/A	All	200	N/A	United States